Group
MedTech Long
23 themes166 tickers
10D rank10D#147of 172 groups/172
Curious about healthcare's future? MedTech Long dives into medical devices, advanced diagnostics, and cutting-edge therapies. We track innovation, an aging population, and policy shifts driving growth across AI platforms, regenerative medicine, and beyond.
Dental Tech+4.42%4.3%
Lab & Life Sciences Tools+21.87%4.3%
Lab Research & Trials+50.37%4.3%
Medical Devices-29.17%4.3%
Medical Distribution-3.38%4.3%
Regenerative Med+18.34%4.3%
Trump-Favorable Regs-27.31%4.3%
US Drug Dev Outsourcing+40.97%4.3%
Adv Bio Therapeutics & Regenerative Med+35.80%4.3%
Aging-Driven Procedures & Care+5.91%4.3%
Cancer Diagnostics, Platforms & Care+73.60%4.3%
Centralized Lab Diagnostics+87.37%4.3%
Consumer Platforms-4.17%4.3%
Diagnostic Platforms+34.14%4.3%
Elective Aesthetics-7.04%4.3%
HC Data & Services+36.35%4.3%
Mental Health+68.74%4.3%
Neuromodulation & Neurotechnology Devices+7.36%4.3%
Wearable Health-0.67%4.3%
Consumerized Healthcare-9.72%4.3%
CROs+32.78%4.3%
Diagnostics & Early Detection+63.39%4.3%
Life Science Tools & Bioprocessing+25.51%4.3%
As of Oct 9, 2026, 4:20 AM ET
Themes in this group
| MedTech Long '25: Consumer PlatformsConsumer Platforms | 5 | $3.96B | $19.81B | +1.16% | +6.60% | -2.64% | +4.79% | +9.63% | -4.17% | +5.90% | -38.99% | +5.62% | +17.31% | +52.69% | +14.64% | -6.76% | +4.87% |
| MedTech Long '25: Diagnostic PlatformsDiagnostic Platforms | 7 | $6.28B | $43.99B | -2.98% | +5.01% | +16.29% | +2.12% | +29.97% | +34.14% | +56.41% | -44.03% | +27.76% | +38.82% | +24.13% | +86.75% | +4.41% | +27.80% |
| MedTech Long '25: HC Data & ServicesHC Data & Services | 6 | $3.31B | $19.85B | -0.23% | +0.93% | +1.86% | +3.80% | +32.67% | +36.35% | +133.53% | +46.41% | +1.12% | +15.70% | +45.13% | +78.92% | -9.39% | -1.94% |
| MedTech Long '25: Cancer Diagnostics, Platforms & CareCancer Diagnostics, Platforms & Care | 10 | $5.85B | $58.53B | -2.25% | +0.92% | +12.57% | +0.20% | +58.56% | +73.60% | +329.81% | +88.72% | +17.28% | +38.70% | +58.00% | +205.57% | +4.97% | +11.83% |
| MedTech Long '24: Medical DistributionMedical Distribution | 15 | $20.20B | $303.02B | +0.74% | +0.48% | -3.64% | +0.56% | -7.83% | -3.38% | +6.37% | +41.89% | -3.58% | 0.00% | -11.41% | +5.90% | +1.04% | +1.87% |
| MedTech Long '24: Regenerative MedRegenerative Med | 6 | $884.3M | $5.31B | -0.21% | +0.26% | +6.12% | +1.60% | +3.00% | +18.34% | +48.38% | +33.14% | +5.93% | +30.54% | +8.65% | +22.50% | +0.38% | +1.75% |
| MedTech Long '24: Lab Research & TrialsLab Research & Trials | 7 | $10.06B | $70.44B | -0.32% | -0.59% | +3.49% | +1.64% | +37.62% | +50.37% | +44.47% | +4.82% | +5.32% | +23.35% | +38.93% | +86.10% | +5.83% | +4.17% |
| MedTech Long '26: Consumerized HealthcareConsumerized Healthcare | 16 | $5.87B | $93.99B | -0.90% | -1.46% | -3.37% | -1.89% | +1.73% | -9.72% | +15.50% | -5.71% | -10.51% | -0.65% | +9.43% | +16.51% | -1.12% | -0.63% |
| MedTech Long '25 : US Drug Dev OutsourcingUS Drug Dev Outsourcing | 8 | $3.78B | $30.26B | -1.34% | -1.63% | +9.94% | +0.53% | +42.30% | +40.97% | +49.17% | -16.54% | +10.77% | +40.11% | +70.35% | +71.54% | +10.00% | +12.36% |
| MedTech Long '24: Dental TechDental Tech | 15 | $3.41B | $47.68B | -0.66% | -1.72% | -6.09% | +0.08% | +3.70% | +4.42% | -10.77% | -32.18% | -12.61% | -0.66% | -11.86% | +1.23% | -1.29% | -12.64% |
| MedTech Long '26: CROsCROs | 7 | $50.74B | $355.15B | -0.23% | -2.42% | +3.65% | +0.73% | +18.17% | +32.78% | +26.80% | +29.93% | +3.03% | +31.30% | +47.80% | +69.51% | +8.29% | +10.15% |
| MedTech Long '25: Centralized Lab DiagnosticsCentralized Lab Diagnostics | 4 | $12.03B | $48.13B | -0.86% | -2.58% | +19.64% | +1.37% | +57.68% | +87.37% | +536.14% | +251.01% | +23.59% | +60.70% | +92.81% | +287.95% | +4.37% | +14.78% |
| MedTech Long '25: Mental HealthMental Health | 8 | $2.56B | $20.47B | -1.26% | -2.87% | -6.82% | +1.61% | +64.17% | +68.74% | +253.68% | +178.21% | -3.93% | +29.46% | +63.51% | +144.44% | +2.63% | -13.39% |
| MedTech Long '25: Aging-Driven Procedures & CareAging-Driven Procedures & Care | 11 | $14.25B | $156.79B | -0.73% | -4.13% | -2.45% | +0.88% | -6.24% | +5.91% | +31.60% | +36.11% | -5.50% | +6.54% | +4.48% | +21.27% | -5.09% | -12.89% |
| MedTech Long '26: Life Science Tools & BioprocessingLife Science Tools & Bioprocessing | 14 | $46.42B | $649.95B | -1.63% | -4.76% | +4.49% | +0.01% | +19.69% | +25.51% | +16.42% | -7.15% | +6.89% | +24.40% | +31.62% | +42.29% | -0.32% | +14.12% |
| MedTech Long '26: Diagnostics & Early DetectionDiagnostics & Early Detection | 16 | $27.77B | $444.30B | -0.26% | -4.92% | +8.29% | -2.22% | +34.40% | +63.39% | +132.02% | +108.58% | +10.35% | +35.93% | +41.78% | +127.96% | +8.98% | +8.23% |
| MedTech Long '25: Elective AestheticsElective Aesthetics | 8 | $682.6M | $5.46B | -2.98% | -5.02% | -14.20% | -1.04% | -1.88% | -7.04% | +11.78% | -47.72% | -11.86% | -16.00% | +8.65% | +26.71% | -4.17% | -9.28% |
| MedTech Long '24: Lab & Life Sciences ToolsLab & Life Sciences Tools | 10 | $53.90B | $538.98B | -1.31% | -5.03% | +4.81% | +0.31% | +14.46% | +21.87% | +1.46% | -15.31% | +6.58% | +24.42% | +29.27% | +26.57% | +1.23% | +14.92% |
| MedTech Long '25: Adv Bio Therapeutics & Regenerative MedAdv Bio Therapeutics & Regenerative Med | 6 | $3.79B | $22.73B | -0.33% | -5.19% | -3.46% | -6.09% | +3.94% | +35.80% | +55.54% | +129.67% | -3.69% | +20.47% | -3.56% | +39.85% | +13.60% | +1.77% |
| MedTech Long '25: Wearable HealthWearable Health | 17 | $15.37B | $245.98B | -0.63% | -6.12% | -9.12% | -2.73% | +3.49% | -0.67% | +11.38% | -26.14% | -7.40% | +4.74% | -5.71% | -1.15% | +10.11% | -2.74% |
| MedTech Long '24: Trump-Favorable RegsTrump-Favorable Regs | 8 | $8.07B | $64.55B | +0.42% | -6.67% | -5.64% | -0.18% | -5.75% | -27.31% | -0.21% | +11.03% | -0.86% | +1.19% | -1.01% | -7.08% | +4.48% | +0.18% |
| MedTech Long '24: Medical DevicesMedical Devices | 8 | $22.94B | $183.51B | -2.82% | -13.17% | -11.85% | -3.25% | -24.06% | -29.17% | -6.45% | -12.89% | -9.91% | -3.11% | -16.84% | -25.93% | +1.32% | -5.98% |
| MedTech Long '25: Neuromodulation & Neurotechnology DevicesNeuromodulation & Neurotechnology Devices | 9 | $523.0M | $4.71B | -3.29% | -17.03% | -16.32% | -6.62% | +2.31% | +7.36% | +68.30% | +89.76% | -10.35% | +4.54% | +5.10% | +6.53% | +4.20% | -11.29% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary